Hemochromatosis classification: update and recommendations by the BIOIRON Society

Area of Science:

• Genetics
• Molecular Biology
• Internal Medicine

Background:

• Hemochromatosis (HC) is a genetic disorder causing iron overload (IO) and severe complications like liver cirrhosis and heart failure.
• Advances in iron metabolism reveal HC stems from mutations in multiple genes affecting hepcidin.
• Current HC classification by molecular subtypes is complex and difficult for clinical application.

Purpose of the Study:

• To propose revised recommendations for classifying Hemochromatosis (HC).
• To develop a practical classification system addressing both clinical presentation and molecular basis of iron overload.
• To simplify HC classification for broader clinical utility.

Main Methods:

• Convening a working group from the International Society for the Study of Iron in Biology and Medicine (BIOIRON Society).
• Developing recommendations during a scientific meeting in Heidelberg, Germany.
• Excluding ferroportin disease (formerly type 4a) due to its distinct phenotype.

Main Results:

• Recommendations for an unambiguous HC classification are presented.
• The proposed classification de-emphasizes strict molecular subtypes.
• It favors a system integrating clinical issues with molecular complexity for iron overload disorders.

Conclusions:

• The revised HC classification aims for practical utility, especially when detailed molecular data is unavailable.
• This new scheme simplifies understanding and application of Hemochromatosis classification.
• It facilitates better management of iron overload disorders by clinicians.